Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Globus Med Inc (GMED)

589 + Investors. Track Smart Money conviction in GMED. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -1
Streak
1Q ▼
Buyers last Q
55%

Smart Money Signals — GMED

Based on 600 hedge funds · latest filing: 2026 Q2 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their GMED positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
600 hedge funds hold GMED right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +24% more funds vs a year ago

fund count last 6Q
+118 new funds entered over the past year (+24% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 55% buying

339 buying273 selling
Last quarter: 339 funds bought or added vs 273 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-20 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 73 → 133 → 108 → 88. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

55% of holders stayed for 2+ years

■ 55% conviction (2yr+) ■ 21% medium ■ 23% new
332 out of 600 hedge funds have held GMED for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +24%, value +6%

Value
+6%
Shares
+23%
Last quarter: funds added +24% more shares while total portfolio value only changed +6%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~88 new funds/quarter

71 → 73 → 133 → 108 → 88 new funds/Q
New funds entering each quarter: 73 → 133 → 108 → 88. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 61% veterans vs 26% newcomers

■ 61% veterans ■ 13% 1-2yr ■ 26% new
Entry-cohort mix of 609 holders: 373 (61%) are 2+ year veterans, 79 entered 1–2 years ago, and 157 (26%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 45% AUM from top-100 funds

45% from top-100 AUM funds
63 of 596 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in GMED. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.0
out of 10
Moderate Exit Risk
Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — GMED

In 2026 Q2, 339 hedge funds were net buyers of GMED (88 opened a new position, 251 added to an existing one), while 273 reduced or exited (184 trimmed, 89 sold completely) — a 55% buyer ratio, indicating a slight buying edge. 45% of total institutional value in GMED is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -1 funds (more exits than new entries). Total institutional holders: 600.

Hedge Fund Ownership: GMED

How many hedge funds hold GMED — quarterly history vs. share price
Quarterly hedge fund ownership of GMED vs. share price

Market Analysis: GMED

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: GMED

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

24 top-rated funds 6 high-conviction
Consensus
6.1
/ 10
breadth
×
Elite
5.4
/ 10
conviction
Hedge Fund Positioning: GMED
589 + Investors

Track Smart Money conviction in GMED. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 589 601 -2.0%
13F Shares 119M 105M 13.69%
Total Value $9.09B $8.66B 4.93%
New Positions 85 108 -23
Increased Positions 245 226 +19
Closed Positions 93 64 +29
Reduced Positions 182 181 +1
Total Calls 7 7 -
Total Puts 6 5 20.0%
PUT/CALL Ratio 0.86 0.71 Neutral

Statistics: GMED

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

589 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in GMED. Verified SEC 13F-HR filings.

QUARTER:
Top 25 GMED holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Terril Brothers, INC. 6.55% 321,520 $25.4M
2 Paradice Investment Management LLC 6.23% 493,906 $39.0M
3 Pembroke Management, LTD 4.94% 398,860 $31.5M
4 Global Alpha Capital Management Ltd. 4.06% 856,616 $67.7M
5 Sio Capital Management, LLC 3.95% 301,816 $23.8M
6 Foresight Group Ltd Liability Partnership 3.56% 254,030 $19.8M
7 Sirios Capital Management L P 3.41% 355,019 $28.1M
8 Broadhurst Jeffrey B 3.34% 19,838 $1.6M
9 Lightrock Netherlands B.V. 3.23% 207,151 $16.4M
10 Madison Avenue Partners, LP 3.18% 935,216 $73.9M
11 Varenne Capital Partners 3.12% 238,200 $18.8M
12 Geneva Capital Management LLC 2.57% 1,417,067 $112.0M
13 Hyperion Capital Advisors LP 2.55% 71,476 $5.6M
14 Andrew Hill Investment Advisors, Inc. 2.33% 39,795 $3.1M
15 American Capital Management Inc 2.31% 653,072 $51.6M
16 Sculptor Capital LP 1.93% 3,000,000 $237.0M
17 Paradigm Capital Management Inc/Ny 1.91% 886,499 $70.0M
18 Sterling Investment Advisors, Ltd. 1.90% 144,023 $11.4M
19 Bridge City Capital, LLC 1.71% 94,939 $7.5M
20 Godshalk Welsh Capital Management, Inc. 1.70% 40,000 $3.2M
21 Conscious Wealth Investments, LLC 1.69% 43,097 $3.3M
22 Capital Impact Advisors, LLC 1.64% 370,167 $29.2M
23 Vestal Point Capital, LP 1.57% 850,000 $67.2M
24 Defilade Capital Management, L.P. 1.48% 139,637 $11.0M
25 Anchor Capital Advisors LLC 1.44% 648,338 $51.2M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Globus Med Inc (GMED)

What does the Smart Money Trend signal show for GMED?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their GMED positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for GMED?

Slight buying edge — 55% buying: Last quarter: 339 funds bought or added vs 273 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for GMED holders?

Elite ownership — 45% AUM from top-100 funds: 63 of 596 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in GMED. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held GMED?

55% of holders stayed for 2+ years: 332 out of 600 hedge funds have held GMED for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →